Starling Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $209.2M
Liabilities Breakdown FY2023
Total Liabilities: $152.2M
Asset Breakdown
Total Assets: $209.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $33.5M | 16.0% |
| Accounts Receivable | $42.4M | 20.2% |
| Inventory | $13.7M | 6.5% |
| Property, Plant & Equipment | $10.9M | 5.2% |
| Goodwill | $7.2M | 3.5% |
| Intangible Assets | $17.9M | 8.6% |
| Other Assets | $83.7M | 40.0% |
Liabilities Breakdown
Total Liabilities: $152.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $14.4M | 9.5% |
| Long-Term Debt | $86.8M | 57.0% |
| Other Liabilities | $51.0M | 33.5% |